Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling

References

• Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a Phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25:1960–1966. doi:10.1200/jco.2006.07.952517452677
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–892. doi:10.1056/NEJMoa111320522397650
   PubMed Web of Science ®Google Scholar
• Feldmann G, Dhara S, Fendrich V, et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 2007;67:2187–2196. doi:10.1158/0008-5472.can-06-328117332349
   PubMed Web of Science ®Google Scholar
• Hwang RF, Moore T, Arumugam T, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–926. doi:10.1158/0008-5472.can-07-571418245495
   PubMed Web of Science ®Google Scholar
• Deer EL, González-Hernández J, Coursen JD, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010;39:425–435. doi:10.1097/MPA.0b013e3181c1596320418756
   PubMed Web of Science ®Google Scholar
• Stahle M, Veit C, Bachfischer U, et al. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci. 2003;116:3835–3846. doi:10.1242/jcs.0067912902401
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene. 2004;23:1448–1456. doi:10.1038/sj.onc.120724714973554
   PubMed Web of Science ®Google Scholar
• Handra-Luca A, Vidaud D, Vullierme MP. et al. Plexiform neurofibroma mimicking a pancreatic cystic tumour. Gut. 2005;54:1658–1659. doi:10.1136/gut.2005.07460916227365
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhao B-J, Song J, Jia X-B. Pharmacology and clinical application of plants in epimedium L. Chin Herbal Med. 2016;8:12–23. doi:10.1016/S1674-6384(16)60003-5
   Web of Science ®Google Scholar
• Li SY, Teh BS, Seow WK, Li F, Thong YH. Effects of the plant flavonoid baohuoside-1 on cancer cells in vitro. Cancer Lett. 1990;53:175–181. doi:10.1016/0304-3835(90)90211-f2208077
   PubMed Web of Science ®Google Scholar
• Kim B, Park B. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression. Biochemistry. 2014;53:7562–7569. doi:10.1021/bi501192725407882
   PubMed Web of Science ®Google Scholar
• Song J, Shu L, Zhang Z, et al. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 2012;199:9–17. doi:10.1016/j.cbi.2012.05.00522687635
   PubMed Web of Science ®Google Scholar
• Vonderheide RH, Bajor DL, Winograd R, et al. CD40 immunotherapy for pancreatic cancer. Cancer Immunol Immunother. 2013;62:949–954. doi:10.1007/s00262-013-1427-523589109
   PubMed Web of Science ®Google Scholar
• Heinemann V. Gemcitabine: progress in the treatment of pancreatic cancer. Oncology. 2001;60:8–18. doi:10.1159/00005529011150902
   PubMed Web of Science ®Google Scholar
• Wang WB, Yang Y, Zhao YP, Zhang TP, Liao Q, Shu H. Recent studies of 5-fluorouracil resistance in pancreatic cancer. World J Gastroenterol. 2014;20:15682–15690. doi:10.3748/wjg.v20.i42.1568225400452
   PubMed Web of Science ®Google Scholar
• Storniolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma. Cancer. 1999;85:1261–1268. doi:10.1002/(ISSN)1097-014210189130
   PubMed Web of Science ®Google Scholar
• Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–2413. doi:10.1200/jco.1997.15.6.24039196156
   PubMed Web of Science ®Google Scholar
• Peng YG, Zhang L. Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma. Pharm Biol. 2018;56:43–50. doi:10.1080/13880209.2017.141839129260980
   PubMed Web of Science ®Google Scholar
• Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 2004;64:622–630. doi:10.1158/0008-5472.CAN-03-263614744777
   PubMed Web of Science ®Google Scholar
• Liang C, Shi S, Meng Q, et al. Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going. Exp Mol Med. 2017;49:e406. doi:10.1038/emm.2017.25529611542
   PubMed Web of Science ®Google Scholar
• Binenbaum Y, Na’ara S, Gil Z. Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates. 2015;23:55–68. doi:10.1016/j.drup.2015.10.00226690340
   PubMed Web of Science ®Google Scholar
• Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153–164. doi:10.1016/s0092-8674(02)00625-611832206
   PubMed Web of Science ®Google Scholar
• Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776. doi:10.1038/3503771011048727
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348. doi:10.1038/3507721311357141
   PubMed Web of Science ®Google Scholar
• Fadaka A, Ajiboye B, Ojo O, et al. Biology of glucose metabolization in cancer cells. J Oncological Sci. 2017;3:45–51. doi:10.1016/j.jons.2017.06.002
   Google Scholar
• Ji L, Li L, Qu F, et al. Hydrogen sulphide exacerbates acute pancreatitis by over-activating autophagy via AMPK/mTOR pathway. J Cell Mol Med. 2016;20:2349–2361. doi:10.1111/jcmm.1292827419805
   PubMed Web of Science ®Google Scholar
• Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13:1016–1023. doi:10.1038/ncb232921892142
   PubMed Web of Science ®Google Scholar
• Su -C-C, Hsieh K-L, Liu P-L, et al. AICAR induces apoptosis and inhibits migration and invasion in prostate cancer cells through an AMPK/mTOR-dependent pathway. Int J Mol Sci. 2019;20:1647. doi:10.3390/ijms20071647
   PubMed Web of Science ®Google Scholar
• Liu M-W, Wei R, Su M-X, et al. Effects of Panax notoginseng saponins on severe acute pancreatitis through the regulation of mTOR/Akt and caspase-3 signaling pathway by upregulating miR-181b expression in rats. BMC Complement Altern Med. 2018;18:51. doi:10.1186/s12906-018-2118-829402262
   PubMed Web of Science ®Google Scholar
• Seitz C, Hugle M, Cristofanon S, Tchoghandjian A, Fulda S. The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk. Int J Cancer. 2013;132:2682–2693. doi:10.1002/ijc.2793523151917
   PubMed Web of Science ®Google Scholar
• Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742–758. doi:10.1016/j.cell.2011.10.03322078876
   PubMed Web of Science ®Google Scholar
• Doherty J, Baehrecke EH. Life, death and autophagy. Nat Cell Biol. 2018;20:1110–1117. doi:10.1038/s41556-018-0201-530224761
   PubMed Web of Science ®Google Scholar
• Sakamaki JI, Ryan KM. Autophagy determines the path on the TRAIL to death. Dev Cell. 2016;37:291–293. doi:10.1016/j.devcel.2016.05.01027219055
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–752. doi:10.1038/nrm223917717517
   PubMed Web of Science ®Google Scholar